Details for New Drug Application (NDA): 216438
✉ Email this page to a colleague
The generic ingredient in MICAFUNGIN SODIUM is micafungin sodium. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the micafungin sodium profile page.
Summary for 216438
Tradename: | MICAFUNGIN SODIUM |
Applicant: | Biocon Pharma |
Ingredient: | micafungin sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 216438
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MICAFUNGIN SODIUM | micafungin sodium | INJECTABLE;INTRAVENOUS | 216438 | ANDA | Biocon Pharma Inc. | 70377-075 | 70377-075-91 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70377-075-91) / 5 mL in 1 VIAL, SINGLE-DOSE |
MICAFUNGIN SODIUM | micafungin sodium | INJECTABLE;INTRAVENOUS | 216438 | ANDA | Biocon Pharma Inc. | 70377-076 | 70377-076-91 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70377-076-91) / 10 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 50MG BASE/VIAL | ||||
Approval Date: | May 29, 2024 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | EQ 100MG BASE/VIAL | ||||
Approval Date: | May 29, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription